It has been demonstrated using molecular genetics methods that the formation and maintenance of quiescent center is determined by several genes responsible for the formation of indoleacetic acid (IAA) transporter proteins [24] and transcription factors [19-21, 25]
Coronal brain slices (300 m) were prepared using a vibrating microtome (VT1200s, Leica) and incubated in oxygenated HEPES ACSF solution (28 C) for at least 1 hour

According to the UK SmPC, the most common side effects include: Nausea (very common, affecting more than 1 in 10 people): Usually most pronounced during the first few weeks of treatment and often diminishes with continued use Diarrhoea (common, affecting up to 1 in 10 people): Typically mild to moderate in severity Vomiting (common): More frequent at higher doses Constipation (common): May occur alongside other gastrointestinal effects Abdominal pain or discomfort (common): Relatively frequent during treatment initiation Decreased appetite (very common): An expected effect related to the medication's action Dyspepsia/indigestion (common): May contribute to discomfort after eating Beyond gastrointestinal effects, other recognised adverse reactions include injection site reactions (redness, itching, or swelling at the subcutaneous injection site), fatigue , and dizziness
Phagocytosis by Normal Human Melanocytes In Vitro
Key Takeaways: GLP-1 medications are approved in India for managing type 2 diabetes and, in some cases, weight management